Home - Lyell
bm-navigation: bm-t3-home-navigation
bm-hero: homepage-hero

Curative cell-based immunotherapies for cancer

bm-basic: home-about

ABOUT

We are entering a new era of medicine, where cancer is treated with cellular therapies: living, smart, targeted drugs. While enormous strides have been made, especially in hematologic cancers, the full promise of these therapies still lies ahead. Cell-based immunotherapies have yet to show substantial benefit in solid tumors, which represent the vast majority of cancers.

Our goal is nothing less than to develop curative cell-based immunotherapies for any cancer, with a focus on CAR-Ts and solid tumors.

THE ORIGINS OF ‘LYELL’

What’s in a name?

Sir Charles Lyell was a Scottish geologist who had a breakthrough insight: earth was shaped over millions, not thousands, of years through numerous and continuous geologic events. This simple, expansive insight provided Charles Darwin the flexibility and framework for developing and supporting his theory of evolution. Darwin credited Lyell for giving him the gift of time.

Our company is named for Lyell, because he used a unifying framework that created a simplifying and synthesizing vessel for transformative insights. Similarly, we have a transformative scientific framework for developing cell-based immunotherapies that we believe will cure cancer.

bm-grid: home-founders

FOUNDERS

Our founders are pioneers in CAR-T therapy and protein engineering. They have spent decades developing science in the immunotherapy and protein engineering fields, generating original insights that have put them at the cutting edge of research and drug development.  At Lyell, they do more than advise—they work directly and intensively with the company to design, develop, test and launch the next generation of cell-based immunotherapies.

Together, their insights and expertise will help Lyell create CAR-T cells that overcome the obstacles to efficacy in solid cancers.

Rick Klausner, MD

Founder & CEO

Stan Riddell, MD

Founder

Crystal Mackall, MD

Founder

David Baker, PhD

Founder

TEAM

Our team is comprised of world-class leaders and scientists united by one mission: to develop highly selective, curative cell-based immunotherapies for cancer. Learn about our leadership team and board of directors below.

VIEW TEAM
bm-grid: home-news-grid

NEWS

Press Releases

View our company announcements

Read More

Publications

Read relevant journal articles and white papers

Read More

News

Catch up on the latest news

Read More
VIEW ALL

CAREERS

Help us cure cancer. Join the team.

VIEW CAREERS
bm-grid: home-contact-grid

CONTACT

SAN FRANCISCO

400 East Jamie Court
Suite 301
South San Francisco, CA
94080

SEATTLE

500 Fairview Avenue N
Suite 560
Seattle, WA
98109